[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351176-105":59,"doc-detail-351176-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","gut-lung-microbiota-axis-shapes-the-immune-microenvironment-and-immunotherapeutic-response-in-lung-cancer","Gut-Lung Microbiota Axis Shapes the Immune Microenvironment and Immunotherapeutic Response in Lung Cancer","","The gut-lung axis microbiota plays a pivotal role in shaping the tumor immune microenvironment (TIME) and regulating immunotherapeutic responses in lung cancer. This review highlights that pulmonary and gut microbial dysbiosis drives lung cancer development through inducing chronic inflammation, remodeling the immune microenvironment, and reprogramming metabolism. Distinct microbial signatures include altered diversity and enrichment of specific airway taxa, alongside gut shifts affecting progression. Microbiota-dependent immunotherapy efficacy is linked to responder-enriched beneficial microbes and non-responder immunosuppressive taxa.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gut-lung-microbiota-axis-shapes-the-immune-microenvironment-and-immunotherapeutic-response-in-lung-cancer/351176/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gut-lung-microbiota-axis-shapes-the-immune-microenvironment-and-immunotherapeutic-response-in-lung-cancer/351176.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the gut-lung axis microbiota influence the tumor immune microenvironment (TIME) in lung cancer?","Question",{"text":113,"@type":114},"Pulmonary and gut microbial dysbiosis reshapes TIME by promoting chronic inflammation, remodeling immune function, and reprogramming metabolism.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What microbiota features are associated with immunotherapy responders versus non-responders?",{"text":118,"@type":114},"Responders show enrichment of beneficial microbes such as Akkermansia muciniphila and Bifidobacterium that enhance CD8+ T cell responses, whereas non-responders display higher Gammaproteobacteria and Fusobacterium linked to immunosuppression.",{"name":120,"@type":111,"acceptedAnswer":121},"Which biological mechanisms and pathways are highlighted as mediators of microbiota effects on immunotherapy?",{"text":122,"@type":114},"Systemic immune modulation by microbial metabolites like short-chain fatty acids and activation of signaling pathways including cGAS-STING and CD40L-CD40/NF-κB are emphasized.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351176,1790522411,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(5): 2265-2284. doi: 10.7150/ijbs.126977  \nReview  \nGut-Lung Microbiota Axis Shapes the Immune Microenvironment and Immunotherapeutic Response in Lung Cancer  \nYao Liu1*, Sidao Wang2*, Xuan Xiang2, Yiheng Du2, Qianqian Xue2, Yiran Niu1, Wenbei Peng2, Linlin Ye2, Qiong Zhou2􀀍  \n1. Department of Respiratory and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.  \n2. Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 430000.  \n*These authors contributed equally to this work.  \n􀀍 Corresponding author: Qiong Zhou, PhD, MD, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 430000, [Email: zhouqiongtj@126.com](Email: zhouqiongtj@126.com).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.10.29; Accepted: 2026.01.12; Published: 2026.02.01  \nAbstract  \nThe gut-lung axis microbiota plays a pivotal role in shaping the tumor immune microenvironment (TIME) and regulating immunotherapeutic responses in lung cancer. This review highlights that pulmonary and gut microbial dysbiosis drives lung cancer development through inducing chronic inflammation, remodeling the immune microenvironment, and reprogramming metabolism. Lung cancer patients exhibit distinct microbial signatures characterized by altered microbiotal diversity and enrichment of specific taxa like Streptococcus, Veillonella, and Bacteroidetes in the airways, along with gut microbial shifts involving decreased Firmicutes/Bacteroidetes ratio. These microbial alterations promote tumor progression via activation of pro-inflammatory pathways (e.g., interleukin-17 (IL-17)/interleukin-23 (IL-23) axis) and suppression of antitumor immunity.Notably, the gut-lung microbiome exerts a profound impact on immunotherapeutic efficacy: responders are enriched with beneficial microbes like Akkermansia muciniphila and Bifidobacterium that enhance CD8⁺ T cell responses, while non-responders show elevated levels of Gammaproteobacteria and Fusobacterium associated with immunosuppression. Regulatory mechanisms include systemic immune modulation by microbial metabolites such as short-chain fatty acids, as well as activation of key signaling pathways including cGAS-STING and CD40L-CD40/NF-κB. Emerging translational applications encompass lung cancer diagnosis and immunotherapeutic response prediction via microbial biomarkers, as well as therapeutic interventions including fecal microbiota transplantation (FMT) and probiotic supplementation. Future studies should clarify microbe-host interaction mechanisms and develop personalized microbiota-based strategies to overcome immunotherapy resistance, offering the potential to revolutionize precision oncology through integrating microbiota modulation with conventional therapies.  \nKeywords: lung cancer, gut-lung axis, immunotherapy, microbiota  \nIntroduction  \nEmerging epidemiological data reveal that in 2023, lung cancer accounted for approximately 2.30 million new cases and 2.04 million deaths globally, ranking first among all malignant neoplasms [1] . Projections indicate that in 2025, the United States will record 226,650 incident cases of lung cancer,  \nrepresenting approximately 11.1% of all new cancer diagnoses, with 124,730 attributable deaths constituting about 20.2% of total cancer mortality [2] . This highlights an urgent need for revolutionary breakthroughs in current diagnostic and therapeutic","cbCaiqsmD3ISWTvI","https://ap.wps.com/l/cbCaiqsmD3ISWTvI","pdf",3140369,"English","# Abstract\n# Introduction\n## Background and epidemiology\n## Immunotherapy landscape and limitations\n## Gut-lung microbiota and emerging evidence","[{\"question\":\"How does the gut-lung axis microbiota influence the tumor immune microenvironment (TIME) in lung cancer?\",\"answer\":\"Pulmonary and gut microbial dysbiosis reshapes TIME by promoting chronic inflammation, remodeling immune function, and reprogramming metabolism.\"},{\"question\":\"What microbiota features are associated with immunotherapy responders versus non-responders?\",\"answer\":\"Responders show enrichment of beneficial microbes such as Akkermansia muciniphila and Bifidobacterium that enhance CD8+ T cell responses, whereas non-responders display higher Gammaproteobacteria and Fusobacterium linked to immunosuppression.\"},{\"question\":\"Which biological mechanisms and pathways are highlighted as mediators of microbiota effects on immunotherapy?\",\"answer\":\"Systemic immune modulation by microbial metabolites like short-chain fatty acids and activation of signaling pathways including cGAS-STING and CD40L-CD40/NF-κB are emphasized.\"}]","Gut-Lung Microbiota Axis Shapes the Immune Microenvironment and Immunotherapeutic Response in Lung Cancer | PDF",1790092906,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9172afc75c3f306ae314262a4301fe5.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c104d6a14c619ade2fbdcf48ce162eb.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d1f034aefda0227b355d614465fac0f.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dea35ee57f36a16892e055d0f0128bb.webp",980,1268]